Cardiac CT Function Software Application vs Tempus ECG-Low EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Circle Cardiovascular Imaging Inc. (Circle CVI)
VS
by Tempus

AI Verdict

Tool A offers comprehensive quantitative analysis of cardiac function and structure derived from CT angiography images, providing detailed metrics like ejection fraction and volumes, alongside plaque analysis. In contrast, Tool B analyzes 12-lead ECG recordings to provide a binary output indicating the likelihood of low left ventricular ejection fraction, serving as a screening or risk stratification tool. While both contribute to cardiac health assessment, their distinct input modalities and levels of diagnostic detail make them complementary rather than direct competitors.

Choose Cardiac CT Function Software Application if…

Choose the Cardiac CT Function Software Application if you require a comprehensive, quantitative analysis of cardiac structure and function from existing CT angiography images. This tool is ideal for detailed assessment of ejection fraction, volumes, myocardial mass, and even coronary plaque, providing advanced visualization and integrated reporting for in-depth diagnostic evaluation.

View Cardiac CT Function Software Application →

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if you need an AI-powered screening tool to quickly identify patients at risk of low left ventricular ejection fraction (LVEF) using standard 12-lead ECG recordings. This solution is best suited for broad patient populations aged 40 and older, aiding clinicians in early detection and guiding further diagnostic workup for potential heart failure.

View Tempus ECG-Low EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cardiac CT Function Software Application Tempus ECG-Low EF
Deployment On-premise (standalone workstation or client/server). The software is vendor-independent and runs on Mac & Windows. It offers DICOM connectivity to PACS and HL7 compatibility for integration into reporting systems. Integrates with current ECG platforms and electronic health records (EHRs).
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiac CT Function Software Application

Tool A offers a comprehensive suite of interactive features, including 2D/3D visualization, multiplanar reconstruction, and detailed reporting with infographics, which enhances the diagnostic workflow for complex CT images. While Tool B provides a simple binary output, Tool A's rich interactive tools and detailed analysis capabilities suggest a higher degree of usability for in-depth clinical review.

Clinical Value

Cardiac CT Function Software Application

Tool A provides direct, quantitative measurements of cardiac function and coronary plaque analysis from CT scans, offering definitive diagnostic information crucial for patient management. Tool B serves as a valuable screening tool for identifying patients at risk of low LVEF from ECGs, prompting further evaluation, but does not provide the same level of definitive diagnostic detail as Tool A.

Pricing & Value

Tie

Both tools require direct vendor contact for pricing, limiting transparency. However, Tool A explicitly mentions flexible pricing models, including volume-aligned and pay-per-process options, which could offer tailored value propositions for different clinical settings. Without specific cost details for either, it is difficult to definitively compare their value.

Enterprise Readiness

Tempus ECG-Low EF

Tool B explicitly confirms HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical for enterprise adoption in healthcare. While Tool A states it is 'likely' HIPAA compliant as an FDA-cleared device, it directs users to contact the vendor for explicit confirmation and BAA details, giving Tool B a slight edge in stated readiness.

Innovation

Tempus ECG-Low EF

Tool B demonstrates significant innovation by leveraging AI to predict low LVEF from readily available and inexpensive 12-lead ECGs, enabling broad-scale screening and early identification of at-risk patients. While Tool A applies advanced AI to complex CT imaging for detailed analysis, Tool B's application to ECGs offers a potentially more impactful and accessible screening solution for a wider population.

Support & Docs

Tie

The provided structured facts for both tools do not contain any information regarding their support services or documentation. Without additional details from web searches or vendor information, it is not possible to differentiate between the two in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cardiac CT Function Software Application Tempus ECG-Low EF
Name Cardiac CT Function Software Application Tempus ECG-Low EF
Company Circle Cardiovascular Imaging Tempus AI
Primary Input Data Multi-phase, multi-slice cardiovascular CT angiography images 12-lead ECG recordings
Primary Output/Metrics Cardiac structure segmentation; quantification of cardiac function metrics (EDV, ESV, SV, EF, CO, CI, LV myocardial mass); coronary plaque analysis Binary output (Low LVEF Detected / Not Detected) for signs associated with low left ventricular ejection fraction (LVEF u226440%)
Specialties Cardiology, Cardiothoracic Surgery, Radiology Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Cardiac CT Function Software Application and Tempus ECG-Low EF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Circle Cardiovascular Imaging's Cardiac CT Function Software Application (Tool A) analyzes multi-phase, multi-slice cardiovascular CT angiography images. Tempus ECG-Low EF (Tool B) analyzes resting, non-ambulatory 12-lead ECG recordings.
Tool A quantifies key function metrics such as ejection fraction, end-diastolic volume, end-systolic volume, stroke volume, and LV myocardial mass, and includes coronary plaque analysis. Tool B provides a binary output (Low LVEF Detected / Not Detected) to identify signs associated with low left ventricular ejection fraction (LVEF u226440%).
Tool A is designed to enhance diagnostic workflows and patient care through AI-powered cardiac CT function analysis. Tool B aids clinicians in identifying patients 40 years or older at risk of heart failure by detecting signs of low LVEF from an ECG, prompting further evaluation.
Tool A is an on-premise software integrated into hospital or private practice environments, pulling DICOM data from PACS. Tool B is also a software solution intended for integration into healthcare facility workflows.
Tool A is utilized for patients undergoing cardiac CT angiography who require detailed cardiac function and anatomical assessment. Tool B is intended for patients 40 years or older who are at risk of heart failure and are undergoing a 12-lead ECG.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.